ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $264,663 | -51.9% | 8,394 | -61.0% | 0.19% | -54.8% |
| Q3 2023 | $550,296 | -19.4% | 21,538 | -9.6% | 0.42% | -5.6% |
| Q2 2023 | $683,158 | +16.6% | 23,820 | -2.5% | 0.45% | +9.0% |
| Q1 2023 | $585,707 | +47.2% | 24,435 | +4.2% | 0.41% | +24.2% |
| Q4 2022 | $398,000 | +15.0% | 23,441 | +0.3% | 0.33% | +13.0% |
| Q3 2022 | $346,000 | -71.2% | 23,362 | -69.4% | 0.29% | +6.2% |
| Q2 2022 | $1,200,000 | +93.5% | 76,250 | +231.3% | 0.28% | -34.0% |
| Q1 2022 | $620,000 | -20.0% | 23,013 | +9.9% | 0.42% | -20.1% |
| Q4 2021 | $775,000 | -19.8% | 20,949 | +3.6% | 0.52% | -21.6% |
| Q3 2021 | $966,000 | +57.6% | 20,223 | +11.6% | 0.67% | +60.0% |
| Q2 2021 | $613,000 | – | 18,122 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |